Tactile Systems Technology, Inc.

Equities

TCMD

US87357P1003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
14.28 ^USD	-1.14%		-0.17%	-0.17%

Apr. 23	Tactile Systems Technology, Inc. Announces CEO Transition	CI
Apr. 23	Tactile Systems Technology, Inc. Provides Preliminary Revenue Guidance for the First Quarter 2024	CI

Tactile Systems Technology, Inc. Provides Preliminary Revenue Guidance for the First Quarter 2024

April 23, 2024 at 04:05 pm EDT

Tactile Systems Technology, Inc. provided preliminary revenue guidance for the first quarter 2024. Unaudited total revenue for the first quarter of 2024 is expected to be approximately $61 million, compared to $58.8 million in the first quarter of 2023.

Latest news about Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. Announces CEO Transition	Apr. 23	CI
Tactile Systems Technology, Inc. Provides Preliminary Revenue Guidance for the First Quarter 2024	Apr. 23	CI
Transcript : Tactile Systems Technology, Inc., Q4 2023 Earnings Call, Feb 20, 2024	Feb. 20
Tactile Systems Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Tactile Systems Technology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q4 Revenue $77.7M	Feb. 20	MT
Tactile Systems Technology, Inc. Provides Revenue Guidance for the Full Year 2024	Feb. 20	CI
Piper Sandler Cuts Tactile Systems Technology Price Target to $23 From $30, Maintains Overweight Rating	Nov. 07	MT
Tactile Systems Technology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Transcript : Tactile Systems Technology, Inc., Q3 2023 Earnings Call, Nov 06, 2023	Nov. 06
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q3 Revenue $69.6M, vs. Street Est of $69.1M	Nov. 06	MT
Tactile Systems Technology, Inc. Updates Earnings Guidance for the Full Year 2023	Nov. 06	CI
Tactile Systems Technology, Inc. Appoints Vindell Washington as Board of Directors	23-10-01	CI
Oppenheimer Adjusts Tactile Systems Technology Price Target to $30 From $24, Maintains Outperform Rating	23-08-08	MT
Tactile Systems Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Transcript : Tactile Systems Technology, Inc., Q2 2023 Earnings Call, Aug 07, 2023	23-08-07
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Posts Q2 Revenue $68.3M, vs. Street Est of $65.3M	23-08-07	MT
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Posts Q2 EPS $0.00, vs. Street Est of $-0.03	23-08-07	MT
Tactile Systems Technology, Inc. Revises Earnings Guidance for the Full Year 2023	23-08-07	CI
Tactile Systems Technology, Inc. Announces Senior Vice President of Sales Changes	23-07-18	CI
Tactile Systems Technology, Inc.(NasdaqGM:TCMD) dropped from Russell Microcap Value Index	23-06-23	CI
Tactile Systems Technology, Inc.(NasdaqGM:TCMD) dropped from Russell 3000E Value Index	23-06-23	CI
Tactile Systems Technology, Inc.(NasdaqGM:TCMD) dropped from Russell 2000 Value Index	23-06-23	CI
Tactile Systems Technology, Inc.(NasdaqGM:TCMD) dropped from Russell 3000 Value Index	23-06-23	CI
Tactile Systems Technology, Inc.(NasdaqGM:TCMD) dropped from Russell Small Cap Comp Value Index	23-06-23	CI

Chart Tactile Systems Technology, Inc.

Duration

Period

More charts

Company Profile

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Tactile Systems Technology, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.28 USD

Average target price

20.67 USD

Spread / Average Target

+44.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
TACTILE SYSTEMS TECHNOLOGY, INC.	-0.17%	339M
SHOCKWAVE MEDICAL, INC.	+73.37%	12.39B
PENUMBRA, INC.	-17.09%	8.08B
MASIMO CORPORATION	+16.88%	7.25B
GETINGE AB	+3.57%	5.86B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+11.77%	5.35B
APT MEDICAL INC.	+29.65%	4.63B
ASAHI INTECC CO., LTD.	-17.74%	4.19B
INARI MEDICAL, INC.	-35.26%	2.44B
SKAN GROUP AG	+3.09%	2.07B

Medical Equipment